IART - Integra Lifesciences Holdings Corp

NYSE * Health Care * Health Care Equipment & Supplies

$11.03

$-0.03 (-0.27%)

About Integra Lifesciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

IART Key Statistics

Market Cap

$861.99M

0

P/B Ratio

0.76

EPS

$-6.74

Revenue Growth

-0.0%

Profit Margin

-0.3%

Employees

4,427

How IART Compares to Peers

IART is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 1

Margin Rank

#2

of 2

Growth Rank

#2

of 2

Size Rank

#2

of 2

CompanyP/EGrowthCompare
IARTN/A-0%-
AMZN34.60%vs AMZN

Integra Lifesciences Holdings Corp Company Information

Headquarters
New Jersey; U.S.A
Website
www.integralife.com
Sector
Health Care
Industry
Health Care Equipment & Supplies
Data Updated:
Ready to invest in IART?

Commission-free trading available. Affiliate links.

IART Lician Score

10% confidence
5.0/10
Neutral

IART has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates IARTacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

IART Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

35810Value5.0Growth3.0Quality5.0Momentum5.0Safety5.04.6/10
5.0

Value

3.0

Growth

5.0

Quality

5.0

Momentum

5.0

Safety

Upcoming Events for IART